Jane Wasman - Sep 16, 2022 Form 4 Insider Report for ATHERSYS, INC / NEW (ATHX)

Role
Director
Signature
/s/ Barb Cameron, as attorney-in-fact for Jane Wasman
Stock symbol
ATHX
Transactions as of
Sep 16, 2022
Transactions value $
$0
Form type
4
Date filed
9/20/2022, 01:39 PM
Previous filing
May 23, 2022
Next filing
Jan 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATHX Common Stock Award $0 +12.8K $0.00 12.8K Sep 16, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATHX Stock Option (right to purchase) Award $0 +32K +100% $0.00 64.1K Sep 16, 2022 Common Stock 32K $1.95 Direct F3
holding ATHX Stock Option (right to purchase) 4K Sep 16, 2022 Common Stock 4K $47.00 Direct F4, F5
holding ATHX Stock Option (right to purchase) 2K Sep 16, 2022 Common Stock 2K $38.50 Direct F4, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the exempt acquisition of 12,820 restricted stock units that in general will vest in total on December 31, 2022, subject generally to the Reporting Person's continued service on the Issuer's Board of Directors.
F2 On August 26, 2022, the Issuer effected a 1-for-25 reverse stock split of its Common Stock (the "Reverse Stock Split").
F3 Represents the exempt acquisition of stock options to purchase 32,042 shares of the Issuer's Common Stock at a per share exercise price of $1.95. These stock options in general will vest on July 28, 2023, subject generally to the Reporting Person's continued service on the Issuer's Board of Directors.
F4 This option has been adjusted to reflect the Reverse Stock Split (in prior reports, this option was previously reported as covering a number of shares equal to this reported amount times 25 (and at an exercise price equal to this reported exercise price divided by 25)).
F5 Stock option vests one-third on November 12, 2021 and thereafter ratably on a quarterly basis over a two-year period.
F6 These stock options vested ratably on a quarterly basis over a one-year period from the date of grant. Award is now fully vested.